Overweight Clinical Trial
Official title:
Evaluation of Therapy for Overweight Children and Adolescents in Switzerland: Therapy in Multiprofessional Group Programs - Part 2, Collection and Analysis of Data
The aim of this pilot project is to disseminate multiprofessional group programs (*MGP*) for therapy of the estimated 119'140 overweight/obese children in Switzerland. Family-based behavioral MGPs have been implemented from 2009 to 2013 to determine changes of health and family behaviours, after the intensive phase (*T1*), at 1 and 2 years after start (*T2*, *T3*). MGP costs are reimbursed in Switzerland: 1) if 116 sessions are provided by experts in physical activity, nutrition and psychology; 2) if parents are included and if their adherence is higher than 85%. In the nationwide "Evaluation of Multiprofessional Group Programs for Paediatric Obesity Therapy" (*KIDSSTEP*) study, multiple psychosocial and physical parameters were assessed at T0, T2 and T3 . Out of 33 certified centers, 25 were active and only 19 were re-certified in 2013/2014. Obese children suffer from major co-morbidities and therefore, only one third of referred patients can be treated in MGPs and their beneficial effects on obesity as well as physical and mental health outcomes are sustained over 2 years.
In Switzerland, the number of overweight children <18 years is estimated to 80'000 and
related cardiovascular, osteoarticular and other complications are already present in
approximately in 50% of these youth. Controlled studies demonstrated that multiprofessional
treatment programs can reduce adiposity and improve health risk factors. To pre-empt the
deterioration of obesity and co-morbidities in adult life, the Swiss Department of the
Interior (EDI) approved in 2007 the reimbursement of treatment of overweight children by
health insurances , if conducted in certified multi-professional family-based group programs.
All programs have to participate in a scientific evaluation study supported by the Federal
Office of Public Health (FOPH) in order to determine nationwide outcomes in clinical
practice. The goal of this study is to evaluate individual changes of physical activity,
nutrition, behaviours, quality of life, co-morbidities and adiposity during therapy and to
identify predictors of positive or negative changes.
During 5 years, the investigators will recruit about 200 children and adolescents aged 6 to
18 years every year. Patients must have a Body Mass Index (BMI), fat mass or waist
circumference above the 97th percentile, or a BMI above the 90th percentile plus a
co-morbidity. Together with their parents they will be enrolled in an intensive group therapy
program for 6 to 12 months, with 12 months of follow up. To date, in 25 certified centres,
physicians, nutrition and physical activity specialists as well as psychologists can provide
a multiprofessional standardized care, the costs of participation being reimbursed after
regular presence. At start, after 1 year and 2 years, standardized instruments validated in
Swiss or European children will be used to document changes during therapy. Questionnaires
will assess motivation, weight of parents, personal and family history, quality of life,
child and family lifestyle, parenting skills, eating or psychological disorders, and
satisfaction. Other investigations will include medical examination, blood tests, and
European Fitness (*Eurofit*)-test for physical fitness and capacities. Anonymised data will
be recorded centrally in an electronic database, after controlling for completeness and
plausibility. Informed consent and positive votes of local ethical committees will be
obtained. Reports on cross-sectional and longitudinal descriptive statistics and benchmarking
will be provided once yearly. A comprehensive multivariate analysis of complex associations
between predictors and health-related outcomes will be completed. Statistical analyses will
be performed by specialists in each field and will be supervised by public health scientists.
To guarantee meaningful analyses, the last patients will be included in December 2013.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Terminated |
NCT03299881 -
Safety and Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS)-Assisted Weight Loss
|
N/A | |
| Completed |
NCT02805478 -
Fat-Associated Cardiovascular Organ Dysfunction
|
||
| Active, not recruiting |
NCT02558920 -
Meta-analyses of Food Sources of Fructose-Containing Sugars and Obesity
|
||
| Completed |
NCT03759743 -
Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject
|
N/A | |
| Completed |
NCT03610958 -
Safety and Performance Evaluation of the Epitomee Device for Enhancing Satiety and Weight Loss.
|
N/A | |
| Completed |
NCT03678766 -
CHARGE: Controlling Hunger and ReGulating Eating
|
N/A | |
| Completed |
NCT04430465 -
Effects of Wholegrains on Children's Health (KORN)
|
N/A | |
| Completed |
NCT04117802 -
Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome
|
N/A | |
| Completed |
NCT05376865 -
Effects of Vitamin D Supplementation on Obesity, Inflammatory and Metabolic Markers
|
N/A | |
| Completed |
NCT03625427 -
Effect of Palmitoleic Acid on C-reactive Protein
|
N/A | |
| Active, not recruiting |
NCT03435445 -
Online Platform for Healthy Weight Loss (POEmaS)
|
N/A | |
| Enrolling by invitation |
NCT05576116 -
Combined Bariatric Surgery and Pancreas After Kidney Transplantation for Type II Diabetics
|
N/A | |
| Recruiting |
NCT05249465 -
Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health Intervention
|
N/A | |
| Active, not recruiting |
NCT06023095 -
A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities
|
Phase 1 | |
| Completed |
NCT03648892 -
Brain Dopamine Function in Human Obesity
|
Early Phase 1 | |
| Not yet recruiting |
NCT05751993 -
Piloting a Reinforcement Learning Tool for Individually Tailoring Just-in-time Adaptive Interventions
|
N/A | |
| Recruiting |
NCT02887950 -
Resistant Starch, Epigallocatechin Gallate and Chlorogenic Acid for Body Weight Loss in Menopause
|
N/A | |
| Completed |
NCT02899390 -
Diabetes Prevention Program in Adults of the Yaqui Tribe of Hermosillo, Sonora at Risk of Diabetes
|
N/A | |
| Terminated |
NCT02743598 -
Liraglutide for HIV-associated Neurocognitive Disorder
|
Phase 4 |